Deepak Khanna president elect of UK ABPI
This article was originally published in Scrip
Deepak Khanna, senior vice-president and MSD UK managing director, has been named president elect of the Association of the British Pharmaceutical Industry. Mr Khanna will take over from current ABPI president Simon Jose (GSK) after the 2012 ABPI AGM in April. He will initially be in the post for one year, with the option of re-election for a further 12 months.
You may also be interested in...
Public Company Edition: Four health care special purpose acquisition vehicles went public and two others announced mergers, but only one biopharma firm priced an IPO during the week of 19-23 October. Replimune’s $250m offering led recent FOPOs.
Wholesalers are given three more years to set up electronic systems to verify saleable returns under another reprieve from the FDA. Yet the reprieve does not extend to manufacturers, who must respond within 24 hours to wholesalers’ requests to manually verify that a returned product is not suspect.
Agency explains how it will model vaccine authorization process on its licensing process for matters like inspections and lot release.